HF Etiology and cardiac contractility modulation therapy.
Karapet V DavtyanIvan ChugunovArpi H TopchyanYury MareevNatalia MironovaElena GupaloSergey GolitsynEvgeny N M MikhaylovDmitry S LebedevMarianna VanderElena A LyasnikovaMaria Yu SitnikovaKhatuna MinjiaSvetlana GlemboOleg SukhorukovPublished in: BMC cardiovascular disorders (2024)
In this multicenter retrospective study, patients with non-ischemic HFrEF showed a significantly higher improvement in LVEF and LV reverse remodeling following CCM therapy device implantation. There was no significant association between HF etiology and survival in drug-resistant HFrEF patients following CCM therapy.
Keyphrases
- drug resistant
- end stage renal disease
- multidrug resistant
- chronic kidney disease
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- stem cells
- prognostic factors
- clinical trial
- cross sectional
- left ventricular
- oxidative stress
- blood brain barrier
- ischemia reperfusion injury
- brain injury
- smooth muscle
- atrial fibrillation
- acute heart failure
- chemotherapy induced